BLISSGVS Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > blissgvs

Technical Analysis

Technical Strength: 7.1 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 74.5. According to RSI analysis, blissgvs is overbought. 3.0 BLISSGVS RSI Chart
MACD (?) MACD: 2.92 and Signal Line: 0.0337. According to MACD analysis, blissgvs is technically strong. 8.0 BLISSGVS MACD Chart
Simple Moving Average (?) According to simple moving average analysis, blissgvs is in a uptrend. Support level is at 165. 9.0 BLISSGVS Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, blissgvs is in a strong uptrend. Major support levels are 165.5076, 164.4174, 161.3404. 10.0 BLISSGVS Exponential Moving Average Chart
Bollinger Bands (?) Bollinger bandwidth suggests that a squeeze has ended and a brekout above the upper band has happened which is a positive signal. %b is 1.15. According to bollinger bands, blissgvs has hit the upper band which is a positive signal. 9.0 BLISSGVS Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 171.394 and 167.5. Resistance level is 184.0. 6.5 BLISSGVS Fibonacci Retracement Chart
Average True Range (?) ATR: 6.13 NA BLISSGVS Average True Range Chart
Average Directional Index (?) ADX is 30.1 which means BLISSGVS is in a trend. NA BLISSGVS Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
October 19, 2017
Open Price 175.15
High Price 184.0
Low Price 175.15
Close Price 182.7
Absolute Change 6.8
Percentage Change 3.87%
Weekly Change 15.2%
Monthly Change 11.1%
Yearly Change 25.4%
52-week high 203.4
52-week low 117.05
Corporate Actions
ExDate Purpose
September 18, 2017 AGM/DIV-RE 0.60 PER SHARE
September 06, 2016 AGM/DIV RE 0.50 PER SHARE
September 08, 2015 AGM/DIV-RE 0.50 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.763
Confidence in Beta6.37%
Market Capital Rs. 1884.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 6.35
TTM Price-to-Earnings (P/E) Ratio 28.8
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 19 October 2017: Deliverable Quantity:1.19e+05 NA BLISSGVS Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 19 October 2017: Daily Volatility:0.5025 NA BLISSGVS Annualized Daily Volatility (Spot Price) Chart

Announcements

September 28, 2017 BlShareholders meetingliss GVS Pharma Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 26, 2017. Further, the company has informed the Exchange regarding voting results.
September 28, 2017 BlShareholders meetingliss GVS Pharma Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 26, 2017
See all Announcements

Board Meetings

Date Meeting Date Purpose
August 29, 2017 September 06, 2017 ToResultso consider inter alia, the Unaudited Standalone and Consolidated Financial Results of the Company for the year ended June 30, 2017.
May 09, 2017 May 16, 2017 tResults/Dividendto consider inter alia, the Audited Standalone and Consolidated Financial Results of the Company for the year ended March 31, 2017 and dividend if any.
See all Board Meetings

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 168.4 Rs. 171.8 Rs. 177.2 Rs. 180.6 Rs. 186.1 Rs. 189.5 Rs. 194.9